0827 GMT - Irish food company Kerry's 3Q update is reassuring within the backdrop of challenging market conditions, Davy Research's Cathal Kenny says in a note. Volume growth of 3% is in line with Davy's expectations, and is positive across three of its regions, confirming model and customer relevancy, Kenny says. The period was busy for business development as Kerry's opened a new biotechnology innovation center in Germany and expanded enzyme capacity in Ireland. The company also invested in cocoa taste capabilities in France, coffee extraction capability in the Americas and taste capacity in the Middle East and East Africa, Kenny says. "We envisage no material change to our constant currency EPS forecast," he says. Shares are up 3.2% at 81.85 euros. (anthony.orunagoriainoff@dowjones.com)
(END) Dow Jones Newswires
October 23, 2025 04:27 ET (08:27 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.